GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » Scaled Net Operating Assets

Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) Scaled Net Operating Assets : 0.80 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hebei Changshan Biochemical Pharmaceutical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hebei Changshan Biochemical Pharmaceutical Co's operating assets for the quarter that ended in Sep. 2024 was ¥4,372 Mil. Hebei Changshan Biochemical Pharmaceutical Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥573 Mil. Hebei Changshan Biochemical Pharmaceutical Co's Total Assets for the quarter that ended in Jun. 2024 was ¥4,775 Mil. Therefore, Hebei Changshan Biochemical Pharmaceutical Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.80.


Hebei Changshan Biochemical Pharmaceutical Co Scaled Net Operating Assets Historical Data

The historical data trend for Hebei Changshan Biochemical Pharmaceutical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hebei Changshan Biochemical Pharmaceutical Co Scaled Net Operating Assets Chart

Hebei Changshan Biochemical Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.77 0.93 0.93 0.91 0.65

Hebei Changshan Biochemical Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.72 0.75 0.80 0.80

Competitive Comparison of Hebei Changshan Biochemical Pharmaceutical Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Hebei Changshan Biochemical Pharmaceutical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hebei Changshan Biochemical Pharmaceutical Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hebei Changshan Biochemical Pharmaceutical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Hebei Changshan Biochemical Pharmaceutical Co's Scaled Net Operating Assets falls into.


;
;

Hebei Changshan Biochemical Pharmaceutical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hebei Changshan Biochemical Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(4365.531-470.173)/6035.803
=0.65

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4596.454 - 230.923
=4365.531

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2796.762 - 813.016 - 1513.573
=470.173

Hebei Changshan Biochemical Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(4372.009-572.616)/4775.111
=0.80

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4686.232 - 314.223
=4372.009

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2914.344 - 766.45 - 1575.278
=572.616

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hebei Changshan Biochemical Pharmaceutical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Hebei Changshan Biochemical Pharmaceutical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hebei Changshan Biochemical Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
North of Yinchuan Street, Zhengding New District, Hebei, Shijiazhuang, CHN, 050800
Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.
Executives
Li Zhi Hua Executives
Wang Jun Executives
Ding Jian Wen Directors, executives
Huang Guo Sheng Executives
Gao Shu Hua Directors, executives
Chen Xi Director
Cai Hao Executives
Ji Sheng Li Directors, executives
Li Xin Securities Affairs Representative
Zhang Wei Secretary Dong
Liu Jian Executives
Zhang Zhi Ying Executives
Guo Yan Xing Supervisors

Hebei Changshan Biochemical Pharmaceutical Co Headlines

No Headlines